Israel Englander Protalix Bio Therapeutics, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 811,160 shares of PLX stock, worth $876,052. This represents 0.0% of its overall portfolio holdings.
Number of Shares
811,160
Previous 10,484
7637.12%
Holding current value
$876,052
Previous $13,000
7200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PLX
# of Institutions
70Shares Held
5.61MCall Options Held
103KPut Options Held
4.6K-
Jim Simons Renaissance Technologies LLC | New York, Ny805KShares$868,9680.0% of portfolio
-
Goldman Sachs Group Inc New York, NY462KShares$498,9140.0% of portfolio
-
Northern Trust Corp Chicago, IL423KShares$457,0700.0% of portfolio
-
Gsa Capital Partners LLP London, X0401KShares$433,3430.03% of portfolio
-
Black Rock Inc. New York, NY333KShares$359,8240.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $53.7M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...